Reata Pharmaceuticals, Inc. (NASDAQ:RETA – Get Free Report)’s stock price reached a new 52-week high during trading on Monday . The stock traded as high as $170.83 and last traded at $170.83, with a volume of 25211 shares. The stock had previously closed at $170.32. Analysts Set New Price Targets Several brokerages have issued reports […]
Farallon Capital Management LLC decreased its holdings in shares of Reata Pharmaceuticals, Inc. (NASDAQ:RETA – Free Report) by 2.1% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 325,000 shares of the company’s stock after selling 7,000 shares during the […]
StockNews.com began coverage on shares of Reata Pharmaceuticals (NASDAQ:RETA – Free Report) in a research report sent to investors on Thursday morning. The firm issued a sell rating on the stock. Several other equities analysts also recently issued reports on the stock. 888 restated a reiterates rating on shares of Reata Pharmaceuticals in a report […]
StockNews com Begins Coverage on Reata Pharmaceuticals (NASDAQ:RETA) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Reata Pharmaceuticals (NASDAQ:RETA) Receives Neutral Rating from Cantor Fitzgerald themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.